ArticleThe breast journal2025

Real-World Efficacy of HLX02-Based Neoadjuvant Therapy in HER2-Positive Breast Cancer: Clinical Insights and Future Directions.

Zhengzhi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.